Stock NANOV THOR MEDICAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials Thor Medical

Equities

NANOV

NO0010597883

Biotechnology & Medical Research

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-29 am EDT 		5-day change 1st Jan Change
1.05 NOK -2.78% Intraday chart for Thor Medical -2.78% -18.60%
Feb. 28 Transcript : Thor Medical ASA, H2 2023 Earnings Call, Feb 28, 2024
Feb. 14 Thor Medical ASA Announces CEO Changes CI

Valuation

Fiscal Period: December 2023
Capitalization 1 301.3
Enterprise Value (EV) 1 259.5
P/E ratio -8.49 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -37,999,461 x
EV / FCF -7,433,565 x
FCF Yield -0%
Price to Book 1.11 x
Nbr of stocks (in thousands) 233,539
Reference price 2 1.290
Announcement Date 3/21/24
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - -
EBITDA - -6.829
EBIT - -7.16
Operating Margin - -
Earnings before Tax (EBT) - -5.561
Net income 1 -311.2 -26.56
Net margin - -
EPS 2 -2.703 -0.1520
Free Cash Flow - -34.91
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 3/21/24 3/21/24
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - -
Net Cash position 1 98.6 41.8
Leverage (Debt/EBITDA) - -
Free Cash Flow - -34.9
ROE (net income / shareholders' equity) - -3.31%
ROA (Net income/ Total Assets) - -2.03%
Assets 1 - 1,307
Book Value Per Share 2 0.5500 1.160
Cash Flow per Share 2 0.8600 0.1800
Capex 1 5.63 -
Capex / Sales - -
Announcement Date 3/21/24 3/21/24
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
THOR MEDICAL Stock Thor Medical
-18.60% 22.43M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.63% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.62% 96.29B
ARGENX SE Stock argenx SE
+1.46% 22.18B
BIONTECH SE Stock BioNTech SE
-16.67% 21.2B
GENMAB A/S Stock Genmab A/S
-8.58% 18.31B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.74% 17.38B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.36B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.41% 13.97B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.57% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. NANOV Stock
  4. Financials Thor Medical